Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03036904
Title Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas (V+DA-EPOCH-R)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University

B-cell lymphoma

diffuse large B-cell lymphoma

non-Hodgkin lymphoma


Cyclophosphamide + Doxorubicin + Etoposide + Prednisone + Rituximab + Venetoclax + Vincristine Sulfate

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.